Recurrent respiratory infections in childhood: experience with a bacterial extract plus bacterial ribosomes (Immucytal®)

A. Fiocchi, R. Arancio, P. Cinquepalmi, M. Sala, G. V. Zuccotti, E. Riva, M. Giovannini

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

A total of 60 children (mean age ±SD 7.6±3.5 years, range 2-14.2 years) with recurrent respiratory infections were treated with bacterial wall extract plus bacterial ribosomes (Immucytal) or placebo sprayed into the nostrils and oropharynx three times a day for 1 or 2-week periods over 3.5 months. The treatment was completed by 58 subjects; two patients in the placebo-treated group were withdrawn, one for poor compliance and the other because of headaches. Respiratory symptoms improved from the first month in the Immucytal treated children, but not in the placebo group, with a reduction in the incidence of infections in the upper and lower airways. No changes were noted in respiratory function parameters. Treatment with Immucytal significantly increased serum immunoglobulin A (P

Original languageEnglish
Pages (from-to)50-60
Number of pages11
JournalJournal of International Medical Research
Volume18
Issue number1
Publication statusPublished - 1990

Fingerprint

Ribosomes
Respiratory Tract Infections
Placebos
Oropharynx
Immunoglobulin A
Headache
Incidence
Therapeutics
Infection
Serum
Ribomunyl

Keywords

  • bacterial ribosomes
  • cell-mediated immunity
  • Membrane glycoprotein
  • paediatrics
  • respiratory infections

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Recurrent respiratory infections in childhood : experience with a bacterial extract plus bacterial ribosomes (Immucytal®). / Fiocchi, A.; Arancio, R.; Cinquepalmi, P.; Sala, M.; Zuccotti, G. V.; Riva, E.; Giovannini, M.

In: Journal of International Medical Research, Vol. 18, No. 1, 1990, p. 50-60.

Research output: Contribution to journalArticle

Fiocchi, A, Arancio, R, Cinquepalmi, P, Sala, M, Zuccotti, GV, Riva, E & Giovannini, M 1990, 'Recurrent respiratory infections in childhood: experience with a bacterial extract plus bacterial ribosomes (Immucytal®)', Journal of International Medical Research, vol. 18, no. 1, pp. 50-60.
Fiocchi, A. ; Arancio, R. ; Cinquepalmi, P. ; Sala, M. ; Zuccotti, G. V. ; Riva, E. ; Giovannini, M. / Recurrent respiratory infections in childhood : experience with a bacterial extract plus bacterial ribosomes (Immucytal®). In: Journal of International Medical Research. 1990 ; Vol. 18, No. 1. pp. 50-60.
@article{61f41f5eaa31489ba7d8a1edc27c27ce,
title = "Recurrent respiratory infections in childhood: experience with a bacterial extract plus bacterial ribosomes (Immucytal{\circledR})",
abstract = "A total of 60 children (mean age ±SD 7.6±3.5 years, range 2-14.2 years) with recurrent respiratory infections were treated with bacterial wall extract plus bacterial ribosomes (Immucytal) or placebo sprayed into the nostrils and oropharynx three times a day for 1 or 2-week periods over 3.5 months. The treatment was completed by 58 subjects; two patients in the placebo-treated group were withdrawn, one for poor compliance and the other because of headaches. Respiratory symptoms improved from the first month in the Immucytal treated children, but not in the placebo group, with a reduction in the incidence of infections in the upper and lower airways. No changes were noted in respiratory function parameters. Treatment with Immucytal significantly increased serum immunoglobulin A (P",
keywords = "bacterial ribosomes, cell-mediated immunity, Membrane glycoprotein, paediatrics, respiratory infections",
author = "A. Fiocchi and R. Arancio and P. Cinquepalmi and M. Sala and Zuccotti, {G. V.} and E. Riva and M. Giovannini",
year = "1990",
language = "English",
volume = "18",
pages = "50--60",
journal = "Journal of International Medical Research",
issn = "0300-0605",
publisher = "Field House Publishing LLP",
number = "1",

}

TY - JOUR

T1 - Recurrent respiratory infections in childhood

T2 - experience with a bacterial extract plus bacterial ribosomes (Immucytal®)

AU - Fiocchi, A.

AU - Arancio, R.

AU - Cinquepalmi, P.

AU - Sala, M.

AU - Zuccotti, G. V.

AU - Riva, E.

AU - Giovannini, M.

PY - 1990

Y1 - 1990

N2 - A total of 60 children (mean age ±SD 7.6±3.5 years, range 2-14.2 years) with recurrent respiratory infections were treated with bacterial wall extract plus bacterial ribosomes (Immucytal) or placebo sprayed into the nostrils and oropharynx three times a day for 1 or 2-week periods over 3.5 months. The treatment was completed by 58 subjects; two patients in the placebo-treated group were withdrawn, one for poor compliance and the other because of headaches. Respiratory symptoms improved from the first month in the Immucytal treated children, but not in the placebo group, with a reduction in the incidence of infections in the upper and lower airways. No changes were noted in respiratory function parameters. Treatment with Immucytal significantly increased serum immunoglobulin A (P

AB - A total of 60 children (mean age ±SD 7.6±3.5 years, range 2-14.2 years) with recurrent respiratory infections were treated with bacterial wall extract plus bacterial ribosomes (Immucytal) or placebo sprayed into the nostrils and oropharynx three times a day for 1 or 2-week periods over 3.5 months. The treatment was completed by 58 subjects; two patients in the placebo-treated group were withdrawn, one for poor compliance and the other because of headaches. Respiratory symptoms improved from the first month in the Immucytal treated children, but not in the placebo group, with a reduction in the incidence of infections in the upper and lower airways. No changes were noted in respiratory function parameters. Treatment with Immucytal significantly increased serum immunoglobulin A (P

KW - bacterial ribosomes

KW - cell-mediated immunity

KW - Membrane glycoprotein

KW - paediatrics

KW - respiratory infections

UR - http://www.scopus.com/inward/record.url?scp=0025021878&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025021878&partnerID=8YFLogxK

M3 - Article

C2 - 2185964

AN - SCOPUS:0025021878

VL - 18

SP - 50

EP - 60

JO - Journal of International Medical Research

JF - Journal of International Medical Research

SN - 0300-0605

IS - 1

ER -